로딩 중…
지수 로딩 중…
Arvinas, Inc.
ARVN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$7.67+0.00%
2026-06-18
Price Chart
Arvinas, Inc.+2.68%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $495M |
| Revenue | $89M |
| Net Income | $-221M |
| Total Assets | $648M |
| Net Assets | $387M |
| Value | |
| P/B | 1.28x |
| P/S | 5.54x |
| FCF Yield | -51.91% |
| Profitability | |
| ROE | -57.21% |
| ROA | -34.18% |
| Op. Margin | -279.31% |
| Revenue Growth | -91.74% |
| Earnings Growth | -169.48% |
| Financial Health | |
| Debt Ratio | 67.40% |
| Total Debt | $9M |
| FCF | $-257M |
| Cash | $87M |
| Current Ratio | 5.44x |
| Performance | |
| 1Y Return | 2.68% |
| 1M Return | -10.29% |
| From 52W High | -47.14% |
| 1Y MDD | -49.53% |
| Trading | |
| Volume | 916,101 shares |
| Trading Value | $7M |
| Per Share | |
| EPS | $-1.24 |
| BPS | $6.69 |